Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0001062993-22-015767

President and CEO acquired 505,050 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gillheeney Gary S. President and CEO 2022-06-30 Option exercise +505,050 $0.99 $500,000 903,292 D
Derivatives
Gillheeney Gary S. President and CEO 2022-06-30 Option exercise · Stock Option (Right to Buy) −505,050 0 D
Loading xslF345X03/form4.xml…